NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,147,000 | +390.2% | 54,550 | +360.1% | 0.03% | +357.1% |
| Q2 2021 | $234,000 | -33.0% | 11,855 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $349,000 | -3.9% | 12,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $363,000 | +90.1% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $191,000 | -25.7% | 12,000 | -7.7% | 0.01% | -38.5% |
| Q2 2020 | $257,000 | +60.6% | 13,000 | 0.0% | 0.01% | +18.2% |
| Q1 2020 | $160,000 | -33.3% | 13,000 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $240,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |